Intelligent Bio Solutions Inc
INBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.39M
Close$
$-15.56
791.7% downside
Current Fair Value
791.7% downsideOvervalued by 791.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.39 Million |
|---|---|
| Enterprise Value | $-3,618,958.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-20 |
| Beta | 4.17 |
| Outstanding Shares | 1,594,496 |
Return
| Return on Equity | -129.59% |
|---|---|
| Return on Assets | -78.13% |
| Return on Invested Capital | -115.25% |
Valuation & Multiples
| P/E Ratio | -0.17 |
|---|---|
| PEG | -1.37 |
| Price to Sales | 1.13 |
| Price to Book Ratio | 0.45 |
| Enterprise Value to Revenue | -0.92 |
| Enterprise Value to EBIT | 0.31 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.51 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$1.40
Average shareholder expectationRevenue Estimate
$7.20 M
Average shareholder expectationNext Earnings Call
Expected Date
August 14, 2026
EPS Estimate
$3.30
Average shareholder expectationRevenue Estimate
$8.80 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.66%▲ 13.40% |
|---|---|
| Total Invested | $1.38M▲ 13.43% |
| Investors Holding | 12▲ 3.00% |
ESG Score
No data
About Intelligent Bio Solutions Inc
8 employeesGBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...